EASL - Home of Hepatology
EASL - Home of Hepatology
  • Видео 540
  • Просмотров 313 814
EASL Studio S7E01 Promo - Are we relearning how to manage renal dysfunction in cirrhosis?
Renal dysfunction is a significant concern for patients with liver cirrhosis, affecting nearly 50% of those hospitalised and leading to various complications that can reduce survival rates. Recently, the diagnostic criteria for acute kidney injury (AKI) and hepatorenal syndrome (HRS) have been updated to better capture the diversity and incidence of these conditions in cirrhotic patients.
This episode of EASL Studio will:
- Explore the updated definitions and standardisation of AKI in the context of cirrhosis.
- Review recent clinical trials, including ATTIRE and CONFIRM, and their implications for patient care.
- Provide a critical analysis of current and emerging strategies for managing ren...
Просмотров: 57

Видео

EASL Policy Dialogues - Inspiring Innovative Action Towards Viral Hepatitis Elimination
Просмотров 8221 день назад
In this episode, two expert speakers delve into the pressing issue of hepatitis and the groundbreaking efforts aimed at its elimination. The discussion will cover the discrimination and stigma experienced by individuals living with hepatitis and examine how these challenges influence advocacy strategies across the EU. Additionally, the episode will explore the future of hepatitis elimination me...
EASL Policy Dialogues - EASL’s statement: Key asks to the EU for the Liver
Просмотров 1012 месяца назад
In April 2024, EASL released a statement to reiterate evidence-based recommendations to the European Union Institutions for the next political term, to address boldly the human and financial burden of liver disease in Europe. Policy makers can no longer ignore the enormous impact on millions of lives across Europe, and on health budgets in every country. The EASL Policy Dialogues Season 3 is su...
EASL Congress 2024 - Wrap up on Metabolism, Alcohol & Toxicity
Просмотров 1,4 тыс.2 месяца назад
EASL Congress 2024 - Wrap up on Metabolism, Alcohol & Toxicity
EASL Congress 2024 - Wrap up on Liver Tumours
Просмотров 1 тыс.2 месяца назад
EASL Congress 2024 - Wrap up on Liver Tumours
EASL Congress 2024 - Wrap up on Viral Hepatitis
Просмотров 1,6 тыс.2 месяца назад
EASL Congress 2024 - Wrap up on Viral Hepatitis
EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic Diseases
Просмотров 9212 месяца назад
EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic Diseases
EASL Congress 2024 - Wrap up on Cirrhosis & Complications
Просмотров 1,4 тыс.2 месяца назад
EASL Congress 2024 - Wrap up on Cirrhosis & Complications
EASL Congress 2024 - Wrap up on Basic Science
Просмотров 5542 месяца назад
EASL Congress 2024 - Wrap up on Basic Science
EASL Love Your Liver projects in Milan, Italy!
Просмотров 2552 месяца назад
Love Your Liver is designed to raise awareness for liver health, promote early detection and care, and build local professional capacities in the hepatology field. The EASL team visited the Scuola Secondaria Mauri in Milan, Italy on 3 June with a host of local hepatologists. This initiative included teaching young pupils the value of keeping the liver healthy and how to do so. The team gave an ...
EASL Studio at EASL Congress 2024 - Landmark studies at the EASL Congress 2024
Просмотров 1302 месяца назад
Thomas Berg (Moderator), Rajiv Jalan (Faculty), Verena Keitel (Faculty), Frank Tacke (Faculty)
EASL Studio at EASL Congress 2024 - Breaking boundaries: innovating the future of hepatitis B and D
Просмотров 912 месяца назад
Breaking boundaries: Innovating the future of hepatitis B and D treatment together Thomas Berg (Moderator), Larry Blatt (Aligos representative), Todd Correll (VIR representative), Susan Dixon (GSK representative), Simon Fletcher (Gilead representative) This EASL Studio is supported by Aligos, Gilead, GSK and VIR
EASL Studio at EASL Congress 2024 - MASLD anno 2024: a rapidly changing landscape
Просмотров 762 месяца назад
Sven Francque (Moderator), Asad Izzidin Dajani (Sanofi representative), Becky Taub (Madrigal Pharmaceuticals representative), Judith Ertle (Boehringer Ingelheim representative), This EASL Studio is supported by Boehringer Ingelheim, GSK, Madrigal Pharmaceuticals, NovoNordisk, and Sanofi
Love Your Liver: Impact Projects 2024 in Padova!
Просмотров 1132 месяца назад
EASL has partnered with University of Padova and Project Third Mission to deliver interactive liver health seminars across Italy in the weeks leading up to the congress. We are teaching young pupils the value of keeping the liver healthy and how to do so. Palermo School: Vittorio Emanuele Orlando, Palermo Rome School: Istituto Comprensivo Suor Celestina Donati Padua School: Scuola secondaria di...
EASL Studio at EASL Congress 2024 - New therapeutic options and remaining challenges in PBC
Просмотров 1512 месяца назад
Thursday 6 June, 16:15 - 16:45, Hepatology Arena & online Verena Keitel (Moderator), Carrie Frenette (CymaBay Therapeutics representatives), Tiago Nunes (Mirum representative), Dimitar Tonev (Ipsen representative), Phil Troke (GSK representative) This EASL Studio is supported by CymaBay Therapeutics, GSK, IPSEN, and Mirum.
Studio at EASL Congress 2024 - Unlocking breakthroughs: Pioneering drug development for ALD&MetALD 1
Просмотров 562 месяца назад
Studio at EASL Congress 2024 - Unlocking breakthroughs: Pioneering drug development for ALD&MetALD 1
EASL Studio at EASL Congress 2024 - Deciphering the drivers of cirrhosis decompensation
Просмотров 682 месяца назад
EASL Studio at EASL Congress 2024 - Deciphering the drivers of cirrhosis decompensation
EASL Studio at EASL Congress 2024 - Exploring new frontiers: The AI liver taskforce initiative
Просмотров 562 месяца назад
EASL Studio at EASL Congress 2024 - Exploring new frontiers: The AI liver taskforce initiative
EASL Studio at EASL Congress 2024 - SLD nomenclature: Need for refinement?
Просмотров 332 месяца назад
EASL Studio at EASL Congress 2024 - SLD nomenclature: Need for refinement?
EASL Studio at EASL Congress 2024 - Advances in systemic treatments in liver cancer
Просмотров 1842 месяца назад
EASL Studio at EASL Congress 2024 - Advances in systemic treatments in liver cancer
EASL Studio S6E15 - What‘s hot in viral hepatitis in 2024?
Просмотров 4902 месяца назад
EASL Studio S6E15 - What‘s hot in viral hepatitis in 2024?
EASL Studio S6E15 Promo - What‘s hot in viral hepatitis in 2024?
Просмотров 2693 месяца назад
EASL Studio S6E15 Promo - What‘s hot in viral hepatitis in 2024?
EASL Congress 2024: THE place to be for Young Investigators!
Просмотров 513 месяца назад
EASL Congress 2024: THE place to be for Young Investigators!
EASL Studio S06E11 - Assessment of significant portal hypertension in 2024
Просмотров 1893 месяца назад
EASL Studio S06E11 - Assessment of significant portal hypertension in 2024
EASL Studio S6 E14 - Endohepatology: The endoscopic liver gold rush
Просмотров 1943 месяца назад
EASL Studio S6 E14 - Endohepatology: The endoscopic liver gold rush
EASL Studio S6E14 Promo - Endohepatology: The endoscopic liver gold rush
Просмотров 2813 месяца назад
EASL Studio S6E14 Promo - Endohepatology: The endoscopic liver gold rush
EASL Congress 2024 - Join us online!
Просмотров 773 месяца назад
EASL Congress 2024 - Join us online!
EASL Studio S6E13 - Resmetirom: First approved drug for MASH, for whom and for how long?
Просмотров 6253 месяца назад
EASL Studio S6E13 - Resmetirom: First approved drug for MASH, for whom and for how long?
EASL Congress 2024: Discover what's in store!
Просмотров 723 месяца назад
EASL Congress 2024: Discover what's in store!
EASL Studio - S6E13 Promo - Resmetirom: First approved drug for MASH, for whom and for how long?
Просмотров 6233 месяца назад
EASL Studio - S6E13 Promo - Resmetirom: First approved drug for MASH, for whom and for how long?